EntryPoint Capital LLC Increases Holdings in Aspen Aerogels, Inc. $ASPN

EntryPoint Capital LLC raised its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 124.9% in the first quarter, Holdings Channel reports. The institutional investor owned 64,810 shares of the construction company’s stock after buying an additional 35,999 shares during the quarter. EntryPoint Capital LLC’s holdings in Aspen Aerogels were worth $414,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Banque Cantonale Vaudoise purchased a new position in Aspen Aerogels during the first quarter valued at $45,000. Exchange Traded Concepts LLC increased its holdings in shares of Aspen Aerogels by 460.4% in the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company’s stock worth $48,000 after purchasing an additional 6,109 shares in the last quarter. CWM LLC increased its holdings in shares of Aspen Aerogels by 2,137.9% in the 1st quarter. CWM LLC now owns 8,325 shares of the construction company’s stock worth $53,000 after purchasing an additional 7,953 shares in the last quarter. Teacher Retirement System of Texas bought a new stake in shares of Aspen Aerogels in the 1st quarter worth $65,000. Finally, Sandia Investment Management LP bought a new stake in shares of Aspen Aerogels in the 4th quarter worth $89,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the business’s stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the completion of the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at approximately $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 4.30% of the company’s stock.

Aspen Aerogels Stock Performance

Shares of ASPN opened at $6.6650 on Thursday. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $32.31. The firm has a market capitalization of $548.93 million, a P/E ratio of -1.75 and a beta of 2.73. The business has a fifty day moving average of $6.89 and a 200 day moving average of $6.85.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company had revenue of $78.02 million during the quarter, compared to analyst estimates of $72.53 million. During the same quarter in the previous year, the company posted $0.21 earnings per share. Aspen Aerogels’s revenue was down 33.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. As a group, sell-side analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have commented on ASPN. Oppenheimer lowered Aspen Aerogels from an “outperform” rating to a “market perform” rating in a report on Thursday, May 8th. Barclays lowered Aspen Aerogels from an “equal weight” rating to an “underweight” rating and lifted their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. Finally, Canaccord Genuity Group reduced their target price on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus price target of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.